In 2020, Gao et al. identified cardiac-hypertrophy-associated piRNA (CHAPIR), a piRNA that is abundantly expressed during cardiac hypertrophy, as a regulator of METTL3 activity. The gene discussed is METTL3; the disease is cardiac hypertrophy.